TORONTO, April 26, 2012 (GLOBE NEWSWIRE) -- GeneNews Limited ("GeneNews" or the "Company") (TSX:GEN) announced today that the requisite shareholder approval was obtained, at the annual and special meeting of shareholders held earlier today, for: (i) a proposed consolidation of the Company's issued and outstanding shares on the basis of one (1) post-consolidation common share for every six (6) pre-consolidation common shares, and (ii) an extension to the term of certain share purchase warrants (the "Warrants").
